(S)-ROSCOVITINE
- Product Name
- (S)-ROSCOVITINE
- CAS No.
- 186692-45-5
- Chemical Name
- (S)-ROSCOVITINE
- Synonyms
- Roscovitine, (S)-Isomer - CAS 186692-45-5 - Calbiochem;(2S)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol;1-Butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2S)-
- CBNumber
- CB71498962
- Molecular Formula
- C19H26N6O
- Formula Weight
- 354.45
- MOL File
- 186692-45-5.mol
(S)-ROSCOVITINE Property
- Melting point:
- 103-106℃
- Density
- 1.25
- storage temp.
- -20C
- form
- White solid
- color
- White to off-white
N-Bromosuccinimide Price
- Product number
- AG-MR-C0002-M005
- Product name
- (S)-Roscovitine
- Purity
- ≥99%(NMR)
- Packaging
- 5mg
- Price
- $90
- Updated
- 2021/12/16
- Product number
- KIN0000007
- Product name
- (S)-ROSCOVITINE
- Purity
- 95.00%
- Packaging
- 1MG
- Price
- $456
- Updated
- 2021/12/16
- Product number
- KIN0000007
- Product name
- (S)-ROSCOVITINE
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $802.38
- Updated
- 2021/12/16
(S)-ROSCOVITINE Chemical Properties,Usage,Production
Uses
(S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent and cross the blood-brain barrier CDKs inhibitor. (S)-Roscovitine shows neuroprotective efficacy. (S)-Roscovitine has the potential for the research of stroke[1][2].
in vivo
(S)-Roscovitine (25 mg/kg; i.p.; 15 min before and 1 hr after pMCAo) shows neuroprotective efficacy in an adult mouse model of permanent MCAo (middle cerebral artery occlusion) [2].
| Animal Model: | 20-25 g, P60 male C57 b/6 mice[2] |
| Dosage: | 25 mg/kg |
| Administration: | I.p.; at 15 min before and 1 hr after pMCAo |
| Result: | Decreased of the total infarct volume. |
IC 50
CDK1: ≤1 μM (IC50); CDK2: ≤1 μM (IC50); CDK5: ≤1 μM (IC50); CDK7: ≤1 μM (IC50); CDK9: ≤1 μM (IC50)
storage
+4°C
References
[1] Le Roy L, et al. Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells. Cells. 2021 Jan 8;10(1):104. DOI:10.3390/cells10010104
[2] Menn B, et al. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS One. 2010 Aug 12;5(8):e12117. DOI:10.1371/journal.pone.0012117
(S)-ROSCOVITINE Preparation Products And Raw materials
Raw materials
Preparation Products
(S)-ROSCOVITINE Suppliers
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 15076683720
- Fax
- 022-23754520
- klq@cw-bio.com
- Country
- China
- ProdList
- 8011
- Advantage
- 55
- Tel
- 15002134094
- marketing@targetmol.cn
- Country
- China
- ProdList
- 29496
- Advantage
- 58
- Tel
- Enzo Biochem Inc. 13797054060
- Enzoname@qq.com
- Country
- China
- ProdList
- 6174
- Advantage
- 58
- Tel
- 51288865780
- sales@biosynth.com
- Country
- China
- ProdList
- 6051
- Advantage
- 58
- Tel
- 13792478491
- Country
- CHINA
- ProdList
- 161
- Advantage
- 58